Takeda Pharmaceutical Agrees to $2.4 Billion Actos Settlement

Rick Nemeroff Founder Published Mar 21, 2016

Late last month, Takeda Pharmaceutical Company – one of the largest pharmaceutical companies in the world – agreed to a $2.4 billion settlement to resolve thousands of lawsuits involving Actos. A popular prescription medication used to treat Type 2 diabetes, Actos has been associated with adverse side effects, including many cases of bladder cancer.

The settlement – reached Tuesday, April 28 th in Illinois Circuit Court of Cook County – will help provide compensation to thousands of victims who claim they were diagnosed with bladder cancer after taking Actos. As part of the settlement terms, Takeda has not admitted wrongdoing.

Takeda came under scrutiny after consumers began reporting bladder cancer diagnoses connected to Actos at alarming rates. After investigating claims, the U.S. Food and Drug Administration (FDA) released a statement that people who took Actos for more than one year faced a 40% increase in bladder cancer risks.

The substantial settlement speaks to the rights of consumers who are harmed by unsafe products and medications. If you have questions about your rights following an illness or injury you believe was caused by a pharmaceutical product, contact Nemeroff Law Firm for a free consultation.

Written By

Rick Nemeroff

Rick Nemeroff, the firm’s founder, is a mesothelioma trial attorney who has won over $100 million for injured clients.

More About Rick Nemeroff

Related Content

Thousands of Xarelto Bottles Recalled Over Contamination Concerns

April 7, 2016 by Rick Nemeroff

Late last month – on Tuesday, October 21 st – Johnson & Johnson’s Janssen unit announced a recall of the popular blood-thinner medication Xarelto (rivaroxaban). According to officials from Janssen, 13,500 bottles of Xarelto are being recalled after microbial contamination was found in a sample. The U.S. Food and Drug Administration (FDA) also released an […]

Researchers Note Rise in Xarelto Prescriptions Despite Increase in Reports of Adverse Events

April 7, 2016 by Rick Nemeroff

In the past several months, concerns over the risks and safety of Xarelto – a popular prescription blood thinner – have been on the rise. In many cases, patients who took Xarelto have reported incidents of severe and uncontrollable bleeding, some serious enough to require hospitalization. A number of injuries and deaths have been associated […]

Xarelto Lawsuits Centralized in Louisiana

April 7, 2016 by Rick Nemeroff

Earlier this month, the U.S. Judicial Panel on Multidistrict Litigation announced the consolidation of federal Xarelto lawsuits in the United States District Court for the Eastern District of Louisiana. The announcement, made on December 12, is considered a turning point in nationwide litigation involving the popular blood-thinner, which has been linked to a number of […]